To compare incidence of shivering with dexmedetomidine and Nalbuphine when used with bupivacaine heavy for spinal anesthesia in lower abdominal surgeries

A comparative study of incidence of Post spinal Anesthesia Shivering associated With use of Dexmedetomidine and Nalbuphine as an adjuvant to 0.5% hyperbaric bupivacaine in lower abdominal surgeries - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072335

Enrollment

Registered

2024-08-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Spinal Anaesthesia: Spinal anaesthesia will be administered at L2-L3 or L3-L4 interspace using a 25 G Quincke’s needle, in the lateral decubitus position. After confirming the free flow

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient undergoing elective surgeries under spinal anaesthesia in whom any grade of shivering was noted. 2. Those who gave informed and written consent. 3. ASA Grade I and II

Exclusion criteria

Exclusion criteria: 1. Those who refused consent. 2. Age less than 20 years 3. ASA Grade III and above 4. Patient allergic to Dexmedetomidine and Nalbuphine 5. Patient with uncontrolled Hypertension, cardiovascular disease, hepatic or renal disease, bronchospastic disease. 6. Psychiatric illness

Design outcomes

Primary

Measure	Time frame
Crossley and Mahajan grading of intraoperative shivering.Timepoint: 0 to 3 hrs	—

Secondary

Measure	Time frame
Changes in hemodynamic parameterTimepoint: 0 to 3 hrs	—

Countries

India

Contacts

Public ContactDr Shashi Prakash

Institute of Medical Sciences Banaras Hindu University

reena216@gmail.com9453047154

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026